What is new in mediastinal staging?
- 26 October 2023
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 30 (1) , 25-34
Abstract
Purpose of review: Appropriate staging is of utmost importance in nonsmall cell lung cancer (NSCLC), as the pathologic stage dictates both overall prognosis and appropriate therapeutic pathways. This article seeks to review the current recommendations for mediastinal staging of NSCLC and available modalities to achieve this. Landmark publications pertaining to recent advancements in NSCLC treatments are also highlighted and the role of specific bronchoscopic modalities for tissue acquisition are reviewed. Recent findings: Recent advancements in the treatment of NSCLC have made accurate mediastinal staging more important than ever. Guidelines and recommendations outlining patients that warrant invasive mediastinal staging are available and a systematic approach should be utilized when sampling is performed. Ensuring the adequacy of tissue for the growing number of molecular biomarkers that must be tested has been the focus of many recent studies. Summary: Appropriate mediastinal staging is crucial for the management of patients with NSCLC as is obtaining adequate tissue for diagnostic and therapeutic purposes. EBUS-TBNA is sufficient for the diagnosis of nonsmall cell and small cell lung carcinomas, but EBUS-guided intranodal forceps and cryobiopsy may provide more optimal specimen for patients with benign disease, such as sarcoidosis, or in cases of lymphoma. Further studies are necessary to better delineate the role of these techniques in the diagnosis and staging of mediastinal diseases before they become the primary diagnostic modalities.Keywords
This publication has 63 references indexed in Scilit:
- False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2012
- A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2011
- The Contribution of Endobronchial Ultrasound-guided Forceps Biopsy in the Diagnostic Workup of Unexplained Mediastinal and Hilar LymphadenopathyLung, 2011
- Positron Emission Tomography-Computed Tomography Compared with Invasive Mediastinal Staging in Non-small Cell Lung Cancer: Results of Mediastinal Staging in the Early Lung Positron Emission Tomography TrialJournal of Thoracic Oncology, 2011
- Endobronchial-Ultrasound Guided Miniforceps Biopsy of Mediastinal and Hilar LesionsThe Annals of Thoracic Surgery, 2011
- Lymph node staging by means of positron emission tomography is less accurate in non-small cell lung cancer patients with enlarged lymph nodes: Analysis of 1145 lymph nodesLung Cancer, 2008
- Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration of Lymph Nodes in the Radiologically and Positron Emission Tomography-Normal Mediastinum in Patients With Lung CancerChest, 2008
- Problems in the current diagnostic standards of clinical N1 non-small cell lung cancerThorax, 2007
- Risk Factors for Occult Mediastinal Metastases in Clinical Stage I Non-Small Cell Lung CancerThe Annals of Thoracic Surgery, 2007
- Comparison of Endobronchial Ultrasound, Positron Emission Tomography, and CT for Lymph Node Staging of Lung CancerChest, 2006